Executive Director, US Brand Lead, Neurology

ultradedicated – Your biggest challenges yield rare possibilities

Ultragenyx is preparing for the potential commercialization of a rare disease Antisense oligonucleotide therapy for the treatment of Angelman Syndrome.  The Executive Director, US Brand Lead, Neurology Therapeutic Area will lead the US launch with accountability for pre-launch activities and execution of commercial launch.  Candidates must have a track record of building a blockbuster rare disease, neurology, pediatric and adult break through treatment seeing through from launch to peak year growth.  The role will report to the SVP, Head of North America Region, Commercial Operations. 

Field: Officially documented as working as a member of the Ultragenyx field team, generally interacting with third parties on behalf of Ultragenyx. 

1. Lead the creation and execution of North America Brand Strategy for GTX 102 for the treatment of Angelman Syndrome in collaboration with cross functional partners and global brand strategy. 
2. Co-Lead cross-functional US launch team for GTX-102 across Sales, Marketing, Medical Affairs, Market Access, Patient Services, Channel Operations, Supply Chain, & Patient Advocacy. 
3. Drive alignment and decision-making among senior stakeholders ensuring launch plans are refined and organizational readiness in place for an exceptional US launch. 
4. Build US disease awareness & brand campaigns including HCP, Patient, and Digital strategy for the brand. 
5. Develop and execute GTX-102 brand strategy and US go-to-market strategy ensuring an exceptional launch for a potential blockbuster breakthrough rare disease therapy. 
6. Hire & lead exceptional neurology team with high patient focus and strong understanding of rare disease commercialization. 

1. 15+ years biopharmaceutical experience with multiple rare disease launch experience in the US with a focus on pediatric and adult rare diseases. 
2. Strong understanding of US rare disease commercialization models including complexities in treatment pathways and unique product to patient models. 
3. Developed innovative and compliant approaches to identify and treat appropriate rare disease patients with a sense of urgency, purpose, and compassion. 
4. Strong understanding of US healthcare system, reimbursement, product to patient models.  
5. Launched scientifically complex treatments from hospital administered & buy & bill models. 
6. Leader with experience in competitive therapeutic areas and demonstrated successful positioning of brands. 
7. Excellent verbal and written communication skills and ability to work and influence in a matrix environment. 
8. Outstanding leadership and interpersonal skills driving projects from planning to implementation, while promoting teamwork between departments. 
9. Takes proactive leadership to support company strategies enrolling leaders and individuals to execute plans in a motivating and respectful manner.  
10. Embraces change, challenges the status quo, and makes recommendations for improvements to products and processes.  
11. Strong ability to work with ambiguity and simplify complex processes into operational processes without creating overly burden processes. 
12. Strong ability to maintain confidentiality as will be exposed to management discussions, confidential material, and strategies in their formative stages. 
13. Approximately 30% travel as needed. 

#LI-AM1 #LI-Remote